Utah Medical Products (UTMD) - Year-over-year earnings per share growth for the last twelve months

High patent barriers in obstetrics protect Utah Medical Products (UTMD) from competition. Business efficiency is based on the margins of niche products and strict FDA control. The quarterly EPS dynamics chart visualizes these successes, where the value is fixed at 6.70. Process stability is maintained by outsourcing component production and international logistics to external contract partners.
UTMD (utahmed.com): analytical breakdowns and indicator data

The quarterly earnings per share growth rate determines the efficiency of business capitalization and the potential for dividend payments. By analyzing comparable quarterly EPS growth, an investor assesses net income dynamics relative to the same period last year. This metric measures the scaling speed of income net of operating expenses. For Utah Medical Products (UTMD), this indicator stabilizes due to the low cyclical demand for medical products. Resilience to macroeconomic shocks guarantees earnings predictability.